D
Deborah Grady
Researcher at University of California, San Francisco
Publications - 276
Citations - 44747
Deborah Grady is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Estrogen & Hormone therapy. The author has an hindex of 88, co-authored 269 publications receiving 43348 citations. Previous affiliations of Deborah Grady include Veterans Health Administration & San Francisco General Hospital.
Papers
More filters
Journal ArticleDOI
Comparison of Risk Factors for Ductal Carcinoma In Situ and Invasive Breast Cancer
TL;DR: Risk factors for DCIS are similar to those for invasive breast cancer and more research is needed to better understand the malignant potential of DCIS lesions and factors that predict which lesions will become invasive breast cancers if left untreated.
Journal ArticleDOI
Should women with familial ovarian cancer undergo prophylactic oophorectomy
TL;DR: The lifetime probability of ovarian cancer increases from about 1.6% in a 35-year-old woman without a family history of cancer to about 5% if she has one relative and 7% if her two relatives with cancer as mentioned in this paper.
Journal ArticleDOI
Smokeless Tobacco Use and Health Effects Among Baseball Players
Virginia L. Ernster,Deborah Grady,John C. Greene,Margaret M. Walsh,P. B. Robertson,Troy E. Daniels,Neal L. Benowitz,David Siegel,Barbara Gerbert,Walter W. Hauck +9 more
TL;DR: Oral leukoplakia among ST users increased with hours used per day and decreased with time lapsed since last use, and was higher in snuff users than in chewing tobacco users, but among users high-density lipoprotein cholesterol levels were inversely associated with serum cotinine levels.
Journal ArticleDOI
Hormone Therapy and In-Hospital Survival After Myocardial Infarction in Postmenopausal Women
TL;DR: Postmenopausal HRT appears to be associated with reduced mortality after myocardial infarction, which could be caused by therapeutic effect of HRT, selection and adherence bias, or some combination of both.
Journal ArticleDOI
The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
TL;DR: In a group of older, postmenopausal women with cardiac disease, it is found no significant effect of 4 years of estrogen plus progestin therapy compared with placebo on knee pain and related disability.